| Schedule of Earnings Per Share, Basic and Diluted |
The following table sets forth the computation of basic and diluted income (loss) per common share attributable to the Company’s stockholders (in thousands, except per share data):
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Numerator: | | | | | | | | | (Loss) income from continuing operations | $ | (176) | | | $ | 12,412 | | | $ | (2,834) | | | $ | 16,409 | | | Income from discontinued operations, net of tax | — | | | 96,227 | | | — | | | 96,250 | | | Net (loss) income | $ | (176) | | | $ | 108,639 | | | $ | (2,834) | | | $ | 112,659 | | | | | | | | | | | Denominator: | | | | | | | | | Weighted average number of shares of common stock outstanding - basic (1) | 47,498,571 | | | 47,398,767 | | | 47,494,677 | | | 47,397,193 | |
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Add: effect of dilutive Series G convertible preferred stock (2) | — | | | 8,582 | | | — | | | 8,582 | | | Add: effect of dilutive restricted stock units | — | | | 427 | | | — | | | — | | | Add: effect of dilutive common stock options | — | | | 227,370 | | | — | | | 97,494 | | | Weighted average number of common shares outstanding – dilutive | 47,498,571 | | | 47,635,146 | | | 47,494,677 | | | 47,503,269 | | | | | | | | | | | Net income (loss) from continuing operations | $ | — | | | $ | 0.26 | | | $ | (0.06) | | | $ | 0.35 | | | Net income (loss) from discontinued operations | — | | | 2.03 | | | — | | | 2.03 | | | Basic net income (loss) per common share | $ | — | | | $ | 2.29 | | | $ | (0.06) | | | $ | 2.38 | | | | | | | | | | | Net income (loss) from continuing operations | $ | — | | | $ | 0.26 | | | $ | (0.06) | | | $ | 0.35 | | | Net income (loss) from discontinued operations | — | | | 2.02 | | | — | | | 2.03 | | | Diluted net income (loss) per common share | $ | — | | | $ | 2.28 | | | $ | (0.06) | | | $ | 2.38 | | (1) Includes: restricted stock awards only when the underlying restrictions expire, the shares are no longer forfeitable, and are thus vested; restricted stock units only when the underlying restrictions expire, the shares are no longer forfeitable, and are thus vested; and contingently issuable shares only when there are no circumstances under which those shares would not be issued. (2) On December 9, 2025, 168 shares of Series G Convertible Preferred Stock were converted to common stock. As a result, no convertible preferred shares are outstanding as of June 30, 2026.
|
| Schedule of Antidilutive Securities |
Anti-dilutive potential shares of common stock are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | Financing Warrants (1) | — | | | 39,774 | | | — | | | 39,774 | | | ABG Warrants (1) | — | | | — | | | — | | | — | | | AllHipHop Warrants (1) | — | | | 5,682 | | | — | | | 5,682 | | | Publisher Partner Warrants (1) | — | | | 9,800 | | | — | | | 9,800 | | | Restricted stock units | — | | | 36,575 | | | — | | | 37,002 | | | Common stock options | 2,996,449 | | | 2,931,149 | | | 2,996,449 | | | 3,061,025 | | | Anti-dilutive securities, excluded | 2,996,449 | | | 3,022,980 | | | 2,996,449 | | | 3,153,283 | |
(1) Financing Warrants, ABG Warrants, AllHipHop Warrants, and Publisher Partner Warrants were all either expired, forfeited, or cancelled as of December 31, 2025.
|